Celldi's core technologies are conjugation and encapsulation.
Two different techniques apply for conjugation and encapsulation new and existing compounds and potency compounds. The mechanism of drugs are released in the human body is different, and makes an effect.
It can be described as an efficient drug delivery technology, and the new drug that binds to Celldi's polymer and the existing used compound, such as dopamine compound, can be called an modified or improved new drug.
Celldi's own polymers are structurally designed such as specific compounds, peptides, or new drug candidates to create a single compound through the combination of Celldi's polymers and candidate compounds.
Such a new polymer-based single compound, through the reaction of specific enzymes present in vivo, breaks the bond between the celldi polymer and the compound and the compound becomes effective in vivo.
Celldi's encapsulation technology is that nanogels capture a single compound.
Nanogel is a type of macromolecular polymer that traps biologically active compounds or molecules of relatively large size.
When entering the body in this state, the reticulum gel breaks down due to the reaction of enzymes present in the body, and the drug is released to show activity.